Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Nek2 is a member of the NIMA-associated protein kinase family and is a special chromosomalin-function (CIN) gene. The Nek2 protein is a key protein regulating mitosis and plays an important role in centrosome separation, spindle formation and mitosis.
Figure 1. Model of the roles of Nek2 in cilia biogenesis and resorption. (Endicott, S. J., et al. 2015)
The Features of Nek2
Nek2 is highly similar to NIMA in the catalytic region, except that Nek2 is not required for cells to enter the mitotic process. Its main role in this process is to regulate the separation of the centrosome. The study found that Nek2 in mammals mainly regulates the centrosomes from G2 to M to the two poles, which plays an important role in the formation of bipolar spindles and the isolation of chromosomes. The complex of Nek2 and protein phosphatase1 (PP) 1 is one of the main regulators of centrosome adhesion and separation, which ensures the smooth entry of the G2 spindle into the M phase. Nek2 is inhibited by PP1 during cell mitosis, and its activity is low. In the late G2 phase, PP1 is gradually inactivated or displaced, resulting in inhibition of Nek2 and increased activity to promote centrosome separation. During the regulation, Nek2 mainly connects two proteins of two unseparated centrosomes by phosphorylation, that is, the centrosome-associated protein 1 and the small root protein are linked to separate them from the central body. Therefore, the expression of Nek2 is increased or the activity is increased, and the inhibition of PP1 and centrosome-associated protein 1 promotes the separation of centrosomes.
In addition to regulating the central body, Nek2 also promotes chromatin condensation and separation of intermediates from histone H3 cells at the centromere, and plays an important role in the accurate separation of chromosomes. The key to Nek2's function is the phosphorylation of cancer-producing proteins. Non-phosphorylated high-expression proteins in cancer interfere with the concentration of chromatin and can cause widespread errors in the adhesion of microtubules to centromeres, which can cause monopolar or multipolar adhesion. Therefore, only phosphorylated cancer-expressed proteins can ensure accurate chromosome segregation.
Nek2 and Tumor
Studies have found that aberrantly expressed Nek2 binds to and further phosphorylates Mad2 and Cdc20, so as to interfere with their role as checkpoints during mitosis, leading to host chromosomal instability leading to tumorigenesis. Studies have shown that overexpression of active Nek2A leads to early differentiation of immature centrosomes, while inactive Nek2A overexpression results in abnormal centrosomes including monopolar spindles and non-integer ploidy. Studies have also found that the expression of Nek2 gene levels is significantly up-regulated in human testicular seminoma. The expression of Nek2 in breast carcinoma in situ and breast invasive carcinoma was significantly higher than that in normal breast tissue, but it was significantly higher in breast invasive carcinoma than in breast carcinoma in situ. Studies have revealed that the mRNA and protein levels of Nek2 expressed by human cholangiocarcinoma cells are significantly higher than those of normal fibroblasts. Nek2 not only participates in centrosome separation, but also participates in chromatin condensation and chromosome segregation. Therefore, Nek2 can indirectly regulate centrosomes and directly interfere with chromosomes to affect the stability of the entire mitotic process, thereby promoting the transformation of cells into malignant hyperplasia. Increased expression and activity of Nek2 is the most common form of expression in tumor cells.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.